About Pharmatek
Pharmatek is a company based in San Diego (United States) founded in 1999 was acquired by Catalent in September 2016. Pharmatek offers products and services including Oral Dose Development, Clinical Supply Services, and Analytical Solutions. Pharmatek operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
Products & Services of Pharmatek
Pharmatek offers a comprehensive portfolio of products and services, including Oral Dose Development, Clinical Supply Services, and Analytical Solutions.
Services for enhancing drug bioavailability and formulation.
Management of packaging, distribution, and storage for trials.
Development and validation of methods for drug stability.
Apps and channels of Pharmatek
its YouTube channel Catalent Pharma Solutions has 7.59K subscribers and 30 videos.
Videos from Pharmatek
The most watched videos on Pharmatek's YouTube channel, Catalent Pharma Solutions (7.59K subscribers). Click a video to play it here.
More on Catalent Pharma Solutions.
Investors in Pharmatek
Pharmatek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Catalent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO offering drug and biologics development services | 2007 | catalent.com | Somerset, United States |
Investor details for Pharmatek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pharmatek
2 dated milestones of Pharmatek across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmatek is founded.
- Exit Acquired by Catalent.
Competitors of Pharmatek
Pharmatek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| biosynth.com | 1966 | Thal, Switzerland | – | – | Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics. |
Detailed competitors of Pharmatek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharmatek
Websites that share an audience with Pharmatek (pharmatek.com).
Websites whose visitors overlap most with Pharmatek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
secure.emmes.com | secure.emmes.com | 100% | – | – | – |
| corerxpharma.com | 92% | – | – | View details | |
clinimetrics.com | clinimetrics.com | 92% | – | – | – |
| algopharm.com | 92% | – | – | View details | |
carolinasresearch.com | carolinasresearch.com | 92% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Pharmatek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Pharmatek
10 companies that operate in the same segment as Pharmatek (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmatek
Pharmatek was founded in 1999.
Pharmatek is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Pharmatek is a pharmaceutical chemistry development and manufacturing organization. It offers contract development services such as compound selection, analytical methods development, preformulation testing, formulation development and manufacturing services such as cGMP manufacturing, packaging, labeling worldwide distribution, stability storage and testing for clinical trial supplies. It offers its services for the development and manufacturing of small molecules, highly-potent cytotoxic (HPC), peptides and poorly soluble compounds. The company claims to specialize in technologies like spray drying and the handling of highly potentcytotoxic compounds. It was acquired by Catalent in September 2016.
Pharmatek's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Pharmatek offers Oral Dose Development, Clinical Supply Services, and Analytical Solutions.
Pharmatek has 1 investor. Key investors include Catalent.
Pharmatek operates through Catalent, Inc.
Yes. Pharmatek was acquired by Catalent in September 2016.